The impact of progenitor enrichment, serum, and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: A controlled trial

Stem Cells

Volumn 21, Issue 1, 2003, Pages 33-40

  Balducci, Elena ^a   Azzarello, Giuseppe ^a   Valenti, Maria Teresa ^a   Capuzzo, Gian Maria ^a   Pappagallo, Giovanni Luigi ^a   Pilotti, Irene ^a   Ausoni, Simonetta ^b   Bari, Marlo ^a   Rosetti, Francesco ^a   Sartori, Donata ^a   Ciappa, Antonino ^c   Porcellini, Adolfo ^a   Vinante, Orazio ^a  

^a PF Calvi Hospital   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Civic Hospital   (Italy)

Author keywords

CD34 selection; Cytokine; Expansion; Serum free media; Stem cell

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CYTOKINE; ERYTHROPOIETIN; FIBRINOGEN RECEPTOR; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 6; PROTEIN; PROTEIN GLYA; RECOMBINANT CYTOKINE; STEM CELL FACTOR; THROMBOPOIETIN; UNCLASSIFIED DRUG;

ARTICLE; BURST FORMING UNIT E; CELL COMPARTMENTALIZATION; CELL CULTURE; CELL FUNCTION; CELL POPULATION; CELL SUBPOPULATION; COLONY FORMING UNIT; COLONY FORMING UNIT GEMM; COLONY FORMING UNIT GM; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKAPHERESIS; MONONUCLEAR CELL; MULTIVARIATE ANALYSIS; STEM CELL; STEM CELL MOBILIZATION;

EID: 0037237507     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.21-1-33     Document Type: Article

References (37)

1. Kessinger A, Armitage JO, Landmark JD et al. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 1988;71:723-727.
2. Sheridan W, Begley CG, Juttner CA et al. Effect of peripheral blood progenitor cells mobilized by filgastrim (G-CSF) on platelet recovery after high dose chemotherapy. Lancet 1992;339:640-644.
3. Schimtz N, Linch DC, Dreger P et al. Randomised trial of filgastrim-mobilized peripheral progenitor cell transplantation vs autologous bone marrow transplantation in lymphoma patients. Lancet 1996;347:353-357.
4. Gribben JG, Neuberg D, Freedman AS et al. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 1993;81:3499-3457.
5. Brugger W, Bross KJ, Glatt M et al. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 1994;83:636-640.
6. Schulze R, Schulze M, Wischnik A et al. Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients. Bone Marrow Transplant 1997;19:1223-1228.
7. Brugger W, Heimfeld S, Berenson RJ et al. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 1995;333:283-287.
8. Reiffers J, Cailliot C, Dazey B et al. Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells. Lancet 1999;354:1092-1093.
9. Knaan-Shonzer S, Verlinden SF, van Beusechem VW et al. Intrinsic potential of phenotypically defined human hemopoietic stem cells to self-renew in short-term in vitro cultures. Exp Hematol 1999;27:1440-1450.
10. Kobari L, Giarratana MC, Poloni A et al. Flt 3 ligand, MGDF, Epo and G-CSF enhance ex vivo expansion of hematopoietic cell compartments in the presence of SCF, IL-3 and IL-6. Bone Marrow Transplant 1998;21:759-767.
11. + cells: effects of FLT3-L and MIP-1α on in vitro expansion of hematopoietic progenitor cells. Haematologica 1999;84:675-682.
12. + cells into rapid division. Exp Hematol 1999;27:1019-1028.
13. Piacibello W, Sanavio F, Garetto L et al. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 1997;89:2644-2653.
14. + cells from bone marrow and peripheral blood of adults need other factors in addition to FL and TPO for optimal expansion in vitro. Exp Hematol 1998;26:706a.
15. Lebkowski JS, Schain LR, Okarma TB. Serum-free culture of hematopoietic stem cells: a review. STEM CELLS 1995;13:607-612.
16. Matsumoto K, Yasui K, Yamashita K et al. In vitro proliferation potential of AC133 positive cells in peripheral blood. STEM CELLS 2000;18:196-203.
17. Eaves CJ, Eaves AC. Erythropoiesis. Hematopoietic Stem Cells. New York, NY: Marcel Dekker Ed, 1985:19-43.
18. Greenhouse SW, Geisser S. On methods in the analysis of profile data. Psycometrika 1959;24:95-112.
19. Bachier CR, Gokmen E, Teale J et al. Ex-vivo expansion of bone marrow progenitor cells for hematopoietic reconstitution following high-dose chemotherapy for breast cancer. Exp Hematol 1999;27:615-623.
20. Pecora AL. Progress in clinical applications of use of progenitor cells expanded with hematopoietic growth factors. Curr Opin Hematol 2001;8:142-148.
21. + hematopoietic progenitor cells with recombinant immunotoxins. Blood 1998;91:1820-1827.
22. Weissman IL. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 2000;287:1442-1446.
23. Larochelle A, Vormoor J, Hanenberg H et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med 1996;2:1329-1337.
24. + progenitors to sustain long-term hematopoiesis in immunodeficient mice after retroviral-mediated transduction. Blood 1997;89:446-456.
25. + cells: committed precursor expansion does not affect immature hematopoietic progenitors. J Hematother 1997;6:151-158.
26. + hematopoietic progenitor cells. Biotechnol Bioeng 1998;60:341-347.
27. Koller MR, Manchel I, Newsom BS et al. Bioreactor expansion of human bone marrow: comparison of unprocessed, density-separated, and CD34-enriched cells. J Hematother 1995;4:159-169.
28. + selected cells. Bone Marrow Transplant 1999;23:1109-1115.
29. Bhatia M, Bonnet D, Murdoch B et al. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med 1998;4:1038-1045.
30. + cell selection in stroma-free cultures. Hematol Cell Ther 1997;39:49-58.
31. + hematopoietic stem cells. Exp Hematol 2000;28:1297-1305.
32. Shadduck RK, Gilmore GL, Lister J. Role of serum-free medium in the ex-vivo expansion of human cord blood hematopoietic stem cells. STEM CELLS 2000;18:154-155.
33. + bone marrow progenitor cells in vitro. Blood 1996;87:1317-1325.
34. Wang J, Doedens M, Dick JE. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 1997;89:3919-3924.
35. Koller MR, Manchel I, Brott DA et al. Donor-to-donor variability in the expansion potential of human bone marrow cells is reduced by accessory cells but not by soluble growth factors. Exp Hematol 1996;24:1484-1493.
36. Yin AH,Miraglia S,Zanjani ED et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997;90:5002-5012.
37. Douay L. Experimental culture conditions are critical for the ex-vivo expansion of hematopoietic cells. J Hematother Stem Cell Res 2001;10:341-346.